Pregnancy CoRonavIrus Outcomes RegIsTrY (PRIORITY)
Clara Health

PRIORITY (Pregnancy CoRonavIrus Outcomes RegIsTrY)

Sponsored by University of California, San Francisco

PRIORITY (Pregnancy CoRonavIrus Outcomes RegIsTrY) is a prospective cohort study of pregnant and recently pregnant women who are: either patients under investigation for COVID-19 or a confirmed case of COVID-19. Data from PRIORITY will be used to evaluate the impact of COVID-19 on the clinical course and pregnancy outcomes of pregnant women and women within 6 weeks of pregnancy.


Coronavirus disease 2019 (COVID-19) is a respiratory illness that can spread from person to person. The virus that causes COVID-19 is a novel coronavirus that was first identified during an investigation into an outbreak in Wuhan, China.

How is this study designed?

Study Type: Observational [Patient Registry] Estimated Enrollment: 1000 participants Actual Study Start Date: March 20, 2020 Estimated Study Completion Date: March 31, 2024

Who is this study for?

Pregnant women or women who have been pregnant in the last 6 weeks and are under investigation for COVID-19 or who have tested positive for COVID-19.

What should I expect?

  • When an eligible patient is referred to the PRIORITY Coordinating Center at UCSF, a UCSF study coordinator will follow-up by phone with the patient and consent verbally.
  • The participant will be asked to complete an approval to release medical information.
  • The investigators will use patient questionnaires to assess symptoms, maternal clinical course, pregnancy outcomes, and neonatal outcomes from initial investigation of COVID-19 to 6 weeks postpartum or 8 weeks following investigation for non-pregnant women enrolled within 6 weeks of pregnancy.
  • The investigators will also obtain all medical records for the participant to data abstract key clinical and pregnancy outcomes.
Inpatient trial

Have questions or need help?

For general questions about COVID-19 clinical trials, please email [email protected] For study specific inquiries, submit the interest form and you'll be connected to the team.